Fingerprint
Dive into the research topics of 'Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia
Ayalew Tefferi, Ruben A. Mesa, Leigh A. Gray, David P. Steensma, John K. Camoriano, Michelle A. Elliott, Animesh Pardanani, Stephen M. Ansell, Timothy G. Call, Gerardo Colon-Otero, Georgene Schroeder, Curtis A. Hanson, Gordon W. Dewald, Scott H. Kaufmann
Research output: Contribution to journal › Article › peer-review
63
Scopus
citations